Document is current
Any future updates will be listed below
-
Authors
Ríos, Ana Sofía
Oxenford, Simón http://orcid.org/0000-0003-2989-3861
Neudorfer, Clemens
Butenko, Konstantin
Li, Ningfei http://orcid.org/0000-0003-3315-3591
Rajamani, Nanditha
Boutet, Alexandre http://orcid.org/0000-0001-6942-5195
Elias, Gavin J. B. http://orcid.org/0000-0002-7495-550X
Germann, Jurgen http://orcid.org/0000-0003-0995-8226
Loh, Aaron
Deeb, Wissam
Wang, Fuyixue http://orcid.org/0000-0001-8975-2775
Setsompop, Kawin
Salvato, Bryan
Almeida, Leonardo Brito de
Foote, Kelly D. http://orcid.org/0000-0002-2436-4138
Amaral, Robert
Rosenberg, Paul B.
Tang-Wai, David F.
Wolk, David A.
Burke, Anna D.
Salloway, Stephen http://orcid.org/0000-0002-2631-0942
Sabbagh, Marwan N.
Chakravarty, M. Mallar
Smith, Gwenn S. http://orcid.org/0000-0003-0706-5440
Lyketsos, Constantine G.
Okun, Michael S. http://orcid.org/0000-0002-6247-9358
Anderson, William S. http://orcid.org/0000-0003-0958-050X
Mari, Zoltan http://orcid.org/0000-0003-0356-9879
Ponce, Francisco A.
Lozano, Andres M. http://orcid.org/0000-0001-8257-3694
Horn, Andreas http://orcid.org/0000-0002-0695-6025
- License Information
-
More Information
Article History
Received: 5 November 2021
Accepted: 27 October 2022
First Online: 14 December 2022
Competing interests
: C.N. was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG NE 2276/1-1). K.F. received grants and personal fees from Medtronic and Boston Scientific, grants from Abbott/St. Jude, and Functional Neuromodulation outside the submitted work. D.W. received grants from Functional Neuromodulation during conduct of this study, grants and personal fees from Avid/Lily, and Merck, personal fees from Jannsen, GE Healthcare, Biogen and Neuronix outside the submitted work. S.S. receives personal fees from Elsai, Lilly, Roche Novartis and Biogen outside the submitted work. M.S. received personal fees from Allergan, Biogen, Roche-Genentech, Cortexyme, Bracket, Sanofi, and other type of support from Brain Health Inc and uMethod Health outside of the submitted work. C.L. received grants from Functional Neuromodulation Inc. during conduct of this study, from Avanir and Eli Lily and NFL Benefits Office outside of the submitted work. M.O. received grants from NIH, Tourette Association of America Grant, Parkinson’s Alliance, Smallwood Foundation, and personal fees from Parkinson’s Foundation Medical Director, Books4Patients, American Academy of Neurology, Peerview, WebMD/Medscape, Mededicus, Movement Disorders Society, Taylor and Francis, Demos, Robert Rose and non-financial support from Medtronic outside of the submitted work. A.L. received grants from Medtronic and Functional Neuromodulation during conduct of this study, personal fees from Medtronic, St. Jude, Boston Scientific, and Functional Neuromodulation outside of submitted work. A.L. disclosed having a patent “US Patent 8,346,365. Lozano AM. Cognitive function within a human brain. 2013” licensed to Functional Neuromodulation. A.H. was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, 424778381 – TRR 295), Deutsches Zentrum für Luft- und Raumfahrt (DynaSti grant within the EU Joint Programme Neurodegenerative Disease Research, JPND), the National Institutes of Health (R01 13478451, 1R01NS127892-01 & 2R01 MH113929) as well as the New Venture Fund (FFOR Seed Grant). ADvance was supported by the National Institute on Aging (R01AG042165) and Functional Neuromodulation Ltd., the sponsor of the study. Other co-authors report no conflicts of interest.
